by Xcellerant Ventures | Jun 11, 2024 | Portfolio Company News
Origionally posted on Empowered Patient Podcast: https://empoweredpatientradio.com/unlocking-the-power-of-crispr-technology-for-drug-development-with-ross-bundy-crispr-qc Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR...
by Tiffany Youtchoko | Jun 1, 2024 | Portfolio Company News
Origionally posted on Genetic Engineering and Biotechnology News: https://www.genengnews.com/topics/genome-editing/crispr-2-0-kinder-gentler-more-powerful-gene-editing/ Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas...
by Xcellerant Ventures | Jan 28, 2024 | Portfolio Company News
Origionally posted on MSN.com: https://www.msn.com/en-us/news/other/big-wins-strategic-moves-and-growth-for-ross-bundy%E2%80%99s-crispr-qc-and-gene-editing/ar-BB1hnksW?disableErrorRedirect=true&infiniteContentCount=0 The field of CRISPR editing has reached a...
by Xcellerant Ventures | Jan 12, 2024 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in CRISPR QC The Xcellerant Venture’s team is proud to lead a Series A funding round for CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first and only CRISPR Analytics Platform. This platform...
by Xcellerant Ventures | Jan 6, 2024 | Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240105587000/en/Xcellerant-Ventures-Ends-First-Year-with-10th-Investment-Leading-CRISPR-QC%E2%80%99s-10-Million-Series-A-Round SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant...
